The Role of DC-SCRIPT in Breast Cancer Prognosis
Author Information
Author(s): Sieuwerts Anieta M, Ansems Marleen, Look Maxime P, Span Paul N, de Weerd Vanja, van Galen Anne, Foekens John A, Adema Gosse J, Martens John WM
Primary Institution: Erasmus Medical Center
Hypothesis
DC-SCRIPT mRNA expression is a prognostic marker in breast cancer.
Conclusion
High levels of DC-SCRIPT are associated with reduced tumor aggressiveness, particularly in small tumors with high ESR1 or low ESR2 levels.
Supporting Evidence
- DC-SCRIPT levels were positively associated with tumor grade and hormone receptor expression.
- Higher DC-SCRIPT levels were linked to better disease-free survival.
- DC-SCRIPT expression was most informative for small tumors and specific receptor statuses.
Takeaway
This study found that a substance called DC-SCRIPT can help predict how aggressive breast cancer will be, especially in smaller tumors.
Methodology
DC-SCRIPT mRNA levels were measured by real-time PCR in 1,505 primary invasive breast cancers and analyzed for associations with disease outcomes using Cox regression.
Potential Biases
Potential biases due to the non-randomized nature of the study.
Limitations
The study is retrospective and may not account for all confounding factors.
Participant Demographics
Female patients with primary operable breast cancer, aged from 1978 to 2000.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI not specified
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website